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Abstract 
Purpose: To evaluate poly (D,L-lactide-co-glycolide) PLGA nanoparticles modified by cetyltrimethyl 
ammonium bromide (CTAB) or chitosan for plasmid DNA adsorption. 
Methods: PLGA nanoparticles were prepared by solvent diffusion method and modified by including 
CTAB in the aqueous (F1) or oil phase (F2), or by including low (F3) or medium (F4) molecular weight 
chitosan. The nanoparticles were characterised by differential scanning calorimetry (DSC) and Fourier 
transform infrared spectroscopy (FTIR), as well as for cell toxicity, cell uptake and transfection. 
Results: CTAB failed to confer positive charge on the nanoparticles. CTAB desorbed easily from F1 
surface. This resulted in negative zeta potential, increased cytotoxicity as well as decreased cell uptake 
and transfection. In F2, CTAB was located mainly in PLGA matrix, resulting in negative charge with 
decreased cytotoxicity, and increased cell uptake and transfection compared to F1. On the other hand, 
chitosan-modified nanoparticles (F3 and F4) showed stronger interaction between chitosan and PLGA, 
leading to positively-charged particles, decreased cytotoxicity, as well as increased cell uptake and 
transfection. Amongst the four formulations, F4 exhibited the highest transfection.  
Conclusion: These results should aid in understanding how PLGA nanoparticles are modified by CTAB 
and chitosan. Modification with chitosan yields PLGA nanoparticles with higher DNA adsorption and 
transfection with lower cytotoxicity.  
 
Keywords: Chitosan, cetyltrimethyl ammonium bromide (CTAB), Nanoparticle, Poly (D,L-lactide-co-
glycolide) PLGA, Plasmid DNA adsorption, Gene therapy 
 
Tropical Journal  of Pharmaceutical Research is indexed by Science Citation Index (SciSearch), Scopus, 
International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African 
Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals 




Poly (D, L-Lactic-co-Glycolic Acid) polymer 
(PLGA) is biodegradable and biocompatible 
polymer widely used in microencapsulation. Its 
robust synthetic pathway allows constructing 
variety of sustained release drug delivery devices 
[1,2]. PLGA nanoparticles and microparticles 
have been frequently used to deliver nucleic 
acids after being modified to become positively 
charged [3]. The positively charged particles 
interact with the negatively charged nucleic acids 
by means of electrostatic interactions to make a 
stable complex that can protect and deliver DNA 
or RNA. Nanoparticles with positive charge are 
more effective than negatively charged ones in 
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the lysosomal escape [4]. Some of the commonly 
used surface modifying materials include 
chitosan [3] and cetyltrimethylammonium 
bromide (CTAB) [5]. 
 
Chitosan is a natural polymer (macromolecule) 
found to confer positive charge onto PLGA 
nanospheres [6]. A positive charge of 10mV at 
pH 7.4 was sufficient to efficiently complex DNA 
electrostatically. PLGA nanoparticles for gene 
therapy need to be taken by cells first to exhibit 
their efficacy. Chitosan coating was found to 
enhance the cell uptake of PLGA nanoparticles 
compared to un-coated nanoparticles [7]. 
Chitosan-PLGA nanoparticles were found also to 
protect plasmid DNA from enzymatic 
degradation, which is important for clinical 
applications [8]. 
 
On the other hand, CTAB is small molecule 
employed as a cationic modifier for PLGA 
nanoparticles in several studies. [9] found that 
CTAB, added to aqueous phase during 
fabrication, remained mainly associated with 
PLGA nanoparticles and ready for DNA 
adsorption, which is in turn associated with 
CTAB content in the nanoparticles. 
Subsequently, the authors modified their 
preparation method to include CTAB in aqueous 
phase at small concentration that was not 
needed to do a washing step [10]. The new 
preparation method was found to be comparable 
to the former one in term of in vivo efficacy. In 
another study, PLGA microparticles modified with 
CTAB were found to have negative or positive 
charge dependent on the polymer used 
(molecular weight and hydrophobicity) [11]. In the 
same study, CTAB-PLGA microparticles were 
more toxic and less effective as gene carrier than 
polyethylenimine (PEI)-PLGA microparticles.  
 
As shown above, the macromolecule chitosan 
and the small molecule CTAB can be used to 
modify PLGA particles for gene delivery but 
different results may be obtained from each one. 
It is not feasible to compare literature directly as 
each study used different polymers from different 
resources. Thus, to compare chitosan and 
CTAB, this study aimed to prepare PLGA 
nanoparticles modified with either CTAB or 
chitosan in total four formulations. Differential 
scanning calorimetry (DSC) and other 
characterisation techniques were employed to 
explore the differences in nanoparticle properties 







PLGA5002A [ratio of lactic to glycolic acid is 
50:50; 0.2 dl/g intrinsic viscosity (IV); acid 
terminated] was kindly provided by PURAC 
(Biochem, Netherland).  Cetyltrimethylammonium 
bromide (CTAB), low molecular weight chitosan 
(LCS) of 50-190 kDa and medium molecular 
weight chitosan (MCS) of 190-310 kDa were 
obtained from Sigma-Aldrich (Germany). 
Polyvinyl alcohol (PVA; MW ~115 kDa, 88% 
hydrolysed) was purchased from BDH 
Laboratory Supplies (Poole, England), 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) was purchased from 
Life Technologies (Grand Island, NY). Green 
fluorescent protein (GFP) Plasmid DNA (pDNA) 
was generously provided by Dr. Michael 
Bradbury (Mount Sinai School of Medicine, 




Four formulations were prepared as listed in 
Table 1. CTAB and chitosan were used to modify 
PLGA nanoparticle surface in order to confer 
positive charge to the particles. Two of the 
formulations were modified with CTAB either in 
aqueous phase (F1) or in oil phase (F2). The 
other two formulations were modified by LCS 
(F3) or MCS (F4). 
 
Table 1: Composition of nanoparticle formulations  
 
Phase/medium F1 F2 F3 F4 






















CTAB Deionised water  LCS MCS 
All the materials were added at a concentration of 1 % w/v 
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Nanoparticle formulations were fabricated by 
modified emulsion solvent-diffusion method [3]. 
Briefly, the oily phase and the aqueous phase 
were homogenised for 3 min at 20,500 rpm using 
IKA® T10 homogeniser (IKA Werke GmbH and 
Co., Germany). The resulting emulsion was 
added to the dispersion medium and stirred for 2 
h under vacuum to enable fast and complete 
evaporation of the organic solvents. 
Nanoparticles were centrifuged, washed three 
times then suspended in one millilitre of 
deionized water. The nanoparticles were 
lyophilized for DSC analysis or kept in 
suspension form in ice bath for zeta potential and 
other measurements. 
 
Differential scanning calorimetry (DSC) 
 
The DSC measurements were conducted on a 
differential scanning calorimeter (DSC1, STARe 
System, Mettler Toledo). Accurate weight of 2-3 
mg of each nanoparticle formulation was put in a 
standard 40 µL aluminium crucible with pin-hole. 
An empty pin-holed crucible was used as 
reference crucible. The thermal program was as 
follows: isothermal at 0 °C for 5 min, heating 
from 0 to 85 °C, cooling to -20°C then heated to 
280 °C. The thermal program for CTAB was: 
equilibrating for 5 min at 20 °C then heating to 
150 °C. In all steps, purging with nitrogen gas 
and heating rate of 10 °C/min were used. The 
thermograms were processed using STARe 
Evaluation Software (Mettler Toledo AG). 
 
Zeta potential and conductivity measure-
ments 
 
Nanoparticles were suspended in deionized 
water at 0.01 % w/v prior to measurement of zeta 
potentials and conductivity by Zeta sizer Nano Z 
attached to a Malvern autotitrator MPT-2 
(Malvern Instruments Ltd, Malvern, 
Worcestershire, UK).  
 
Fourier transform infrared spectroscopy 
(FTIR) 
 
Lyophilised nanoparticles were directly mixed 
with potassium bromide then the discs were 
prepared by compression. FTIR spectra were 
recorded in a Perkin-Elmer FTIR spectrometer 
(Perkin Elmer Corp., Norwalk, CT, USA) in the 
range of 400 – 4000 cm−1 with a resolution of 4 
cm−1. 
 
Evaluation of cytotoxicity of nanoparticles 
 
Neuro 2a (N2a) cells were seeded in 96-well flat-
bottom microplate at a density of 2.5×105 cells 
per well and incubated for 48 h at 37ºC and 5% 
CO2. After that, nanoparticles of the four 
formulations were added to it at different 
concentrations. Following 48 h incubation, the 
media were substituted with MTT reagent (30 
µL). After 4 h incubation, DMSO (120 µL) was 
added. The absorbance was recorded at 570 nm 
using Tecan Infinite 200 microplate reader 
(Tecan Austria GmbH, Grödig, Austria). The 
viability of the cells were expressed as 
percentage relative to the control cells 
(untreated) which was considered as 100 % 
viable. 
 
Assessment of cell uptake of nanoparticles 
by N2a cells 
  
Coumarin-6 was added to the nanoparticle 
formulations as a fluorescent probe. Cell uptake 
study was conducted as we described before 
[12]. N2a cells at a density of 2.5 × 105 cells per 
well were incubated for 48 h at 37 ºC and 5% 
CO2 in a 96-well white flat-bottom microplate. 
Nanoparticles at concentration of 50 µg/mL were 
added to the cells. After 1 h incubation, cells 
were washed with ice-cold PBS three times to 
remove the non-internalised nanoparticles then 
visualised under an Olympus FSX100 
fluorescence inverted microscope (Olympus, 
Tokyo, Japan). To extract and quantify 
coumarine-6, cells were lysed with lysis buffer 
(Promega; Madison, WI) then freeze-dried. The 
fluorescent dye Coumarin-6 was extracted with 
methanol and the fluorescence intensity was 
measured by fluorescence spectrophotometer 
(Perkin Elmer Corp., Norwalk, CT, USA). The 
excitation wave length 450 nm and the emission 
wave length 505 nm were used for the 
fluorescence measurement. 
 
Transfection efficiency  
  
Nanoparticles: pDNA (NP-pDNA) at ratio 20:1 
(w:w) were mixed to make nanoparticle-pDNA 
(NP-pDNA) complexes and used to transfect N2a 
cells. Cells were cultured at 25 × 105 cells per 
well in a 24-well flat-bottom microplate and 
incubated for 48 h at 37 ºC and 5 % CO2. After 
that the media were replaced with fresh media 
containing NP-pDNA complexes and incubated 
for 48 h. Cells were visualised by 
Nikon Eclipse Ti fluorescence microscope and 
the captured images were analysed with 
ImageJ (NIH, Bethesda, MD, USA) to quantify 




Comparison amongst the four formulations were 
done by analysis of variance (ANOVA) with 
Tukey’s post hoc. T-test was employed for 
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comparison within each formulation. P < 0.05 
was considered statistically significant. Minitab 
software version 16 (Minitab, State College, PA) 




Thermal characteristics of nanoparticles 
 
The first heating of F1 showed a wide 
endothermic peak (15.0 – 54.3 °C) clearly 
different from the glass transition in F2 (Figure. 
1). The Tg of F1 and F2 was higher than Tg of 
PLGA alone (Table 2). However, it is more ideal 
to compare with the formulation prepared by 
PLGA in the oil phase and PVA in the aqueous 
phase (i.e., the blank formulation). The Tg of F1 
and F2 was also higher than Tg of blank 
formulation. The Tg of F2 was slightly higher than 
the Tg of F1 (43.8 °C compared to 43.3 °C, Table 
2). The endothermic peak of CTAB around 
102°C was seen in F1 but not in F2. F4 exhibited 
significantly higher Tg (46.7 °C) as compared to 
F3 (42.5 °C) (Figure. 2) and both were higher 
than the Tg of the blank formulation (Table 2). 
 
Nanoparticle physicochemical characteri-
sation: zeta potential, conductivity and FTIR 
 
CTAB-modified nanoparticles (F1 and F2) 
exhibited negative charge with lower value in F2 
(Table 3). On the other hand, chitosan-modified 
nanoparticles (F3 and F4) were positively 
charged with higher zeta potential in LCS-
modified particle (F3). Conductivity measurement 
(Table 3) revealed that F1 and F2 had higher 
conductivity than F3 and F4. No significant 
difference was seen between zeta potential 
values of F1 and F2 after lyophilisation and both 
suffered zeta potential inversion after 
lyophilisation. On the other hand, chitosan-
modified nanoparticles remain positively charged 
after lyophilisation but F3 zeta potential 
decreased while F4 increased. Conductivity 
measurement (Table 3) revealed that CTAB-
PLGA nanoparticles (F1 and F2) had higher 
conductivity than chitosan-PLGA nanoparticles 
(F3 and F4).  
 
   
Figure 1: DSC thermograms for F1 (CTAB in aqueous phase) and F2 (CTAB in oil phase). (1) F1 first heating 
segment; (2) F2 first heating segment; (3) CTAB alone heating segment; (4) F1 second heating segment; (5) F2 
second heating segment 
 
Table 2: Glass transition of PLGA in different blends and formulations 
 
Sample Tg in first heating segment** Tg in second heating 
segment** 
PLGA 41.9 ± 0.07 (C) 37.6 ± 0.10 (α) 
PLGA-PVA physical mixture 37.9 ± 0.10 (G) 40.2 ± 0.11 (β) 
PLGA-LCS physical mixture 40.5 ± 0.17 (E) 39.9 ± 0.09 (γ) 
PLGA-MCS physical mixture 42.1 ± 0.25 (B, C) 39.4 ± 0.15 (δ) 
F1 Not possible due to overlapping of enthalpy 
relaxation peak 
43.3 ± 0.04 (ε) 
F2 47.0 ± 0.07 (A) 43.8 ± 0.06 (ζ) 
F3 38.8 ± 0.06 (F) 42.5 ± 0.08 (η) 
F4 42.3 ± 0.11 (B) 46.7 ± 0.27 (θ) 
Blank particles* 41.0 ± 0.09 (D) 39.3 ± 0.07 (δ) 
*Blank particles were prepared by solely PLGA in oil phase and polyvinyl alcohol (PVA) in aqueous phase without 
further surface modification. **Mean of triplicate in each column in the table were compared by one-way ANOVA 
with Tukey post-hoc test. Means that do not share a letter are significantly different (p < 0.05) 
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Figure 2: DSC thermograms for F3 (LCS-PLGA nanoparticle) and F4 (MCS-PLGA nanoparticle). (1) F3 first 
heating segment; (2) F4 first heating segment; (3) F3 second heating segment; (4) F4 second heating segment. 
 
Table 3: Zeta potential and conductivity of nanoparticles suspended in deionized water (1 mg/10 mL). 
Formulation F1 was measured in three conditions: after normal washing step like other formulations (3 times 
washing with deionised water), without washing and extensive washing (washing 5 times with deionised water).  
 
Formulation Zeta potential (mV) Conductivity (µS/cm) 
* 
 Before lyophilisation* After lyophilisation* NP-pDNA complex*  
F1 
- without washing 
- extensive washing 
-6.45 ± 0.41(a) 
44.07 ± 1.65(b) 
-19.40 ± 2.31(c) 
24.80±3.32(a,b) -17.83±3.40(c) 23.77 ± 0.06(a) 
> 500.0 
3.26 ± 1.68(b) 
F2 -21.43 ± 1.46(c) 19.57±11.64(a,b) -26.90±1.76(d) 66.93±2.76(c) 
F3 38.80 ± 1.32(d) 10.47±0.25(b) 17.50±2.46(a) 12.79±6.44(d) 
F4 14.70 ± 0.89(e) 31.00±4.85(a) 7.35±0.20(b) 5.45± 0.10(b, d) 
*Data were represented as means of triplicate measurements; in each column means that do not share a letter 
are significantly different (p < 0.05). 
 
FTIR spectra for the nanoparticle formulations 
are shown in Figure 3. PLGA exhibited 
characteristic bands at 1761 cm−1 (ester group) 
and 2953 and 2998 cm- (the axial stretching of 
sp2 and sp3 carbons)[6] which appeared at. 
CTAB exhibited several peaks, amongst them 
the -(CH2)- anti-symmetrical stretching at 2918 
cm-1 and the symmetrical stretching at 2850 cm-1 
[13] are the most interesting in this study. 
Chitosan exhibited the characteristic bands of 
NH2 scissoring vibration at 1640 cm-1 and C–O 
stretching vibrations of the pyranose ring at 1075 
and 1031 cm-1 [14,15]. In all formulations, the 
characteristic peaks for PLGA appeared clearly 
in the FTIR spectra. In the case of F1 (CTAB in 
aqueous phase), the two peaks from CTAB at 
2920 and 2852 cm-1 were distinguishable in the 
spectrum. However, these peaks were not 
detected in F2. Chitosan peaks had low 
absorption and seem to be overlapped by PLGA 
peaks in F3 and F4. The increase in height of the 
peak at 1636 cm-1 and the small shoulder 
indicates chitosan presence was clearer in F4. 
 
Nanoparticle biological characteristics 
 
Cytotoxicity of nanoparticles 
 
F1 revealed the highest cytotoxicity as shown in 
Figure 4. On the other hand, despite the 
suggested higher amount of CTAB molecules in 
F2 but their presence in PLGA matrix may 
reduce the toxicity of this formulation. Chitosan-
modified nanoparticles (F3 and F4) exhibited 
relatively low cytotoxicity. The cytotoxicity profile 
was similar between F3 and F4 with slightly 
higher cytotoxicity observed with F3. 
 
 
Figure 4: Cytotoxicity of the four nanoparticle 
formulations on N2a cells by MTT assay. 
 
Cell uptake of nanoparticles by N2a cells 
 
Chitosan-modified nanoparticles were taken up 
more than CTAB-modified nanoparticles (Figure 
5a). Fluorescence inverted microscope images 
showed that almost all the cells in the field  
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Figure 5: N2a cell uptake of coumarine-6 loaded nanoparticles as quantified by fluorimeter (a) and seen by 
fluorescence inverted microscope (b). In Figure 5(a), results were represented as means of triplicate 
measurements; letters over the bars represent the significant difference (p < 0.05, ANOVA with Tukey post-hoc 
test) 
 
successfully took up the nanoparticles during 1 h 
of incubation. 
 
In the case of F2 that can be considered surface-
unmodified nanoparticles, free nanoparticles 
were observed in the field. In F3, some 
nanoparticles can be seen outside but stuck to 
the cells. 
 
Transfection of N2a cells 
 
Particles loaded with pDNA (encoding GFP) by 
adsorption were used to transfect N2a cells. 
Cells were viewed under the fluorescence 
inverted microscope after 48 h to observe any 
expressed GFP (Figure 6a). The captured 
images were then analysed by ImageJ software 
(NIH, Bethesda, MD, USA) to compare the gene 
expression amongst the samples (Figure 6b). 
Image processing was based on the green 
coloured area which represents the number of 
transfected cells. Despite the negative zeta 
potential of F2, it exhibited higher transfection 
than F1 that almost did not show any gene 
expression. On the other hand, chitosan-modified  
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Figure 6: Transfection of N2a with pDNA (encoding GFP)-loaded nanoparticles as seen by fluorescence inverted 
microscope (a) and after image processing of the green colour area (b). In Figure 6(b), results were represented 
as means of triplicate measurements; letters over the bars represent the significant difference (p < 0.05, ANOVA 
with Tukey post-hoc test) 
 
nanoparticles exhibited different transfection 




The low moisture content in the glassy material 
(PLGA) caused the wide endothermic peak (15.0 
– 54.3 °C, Figure 1) in formulation F1 [16], which 
upon heating resulted in structural or enthalpy 
relaxation. The relaxation usually interferes with 
the Tg measurement as the thermal event takes 
place near the Tg. The obvious difference in the 
thermograms of F1 and F2 near Tg in the first 
heating segment suggests that nanoparticle 
micro-structures and properties differ if CTAB 
was added to the aqueous phase or oil phase. It 
was reported that CTAB adsorption on PLGA 
microparticles was mainly due to the hydrophobic 
and other weak interactions of the carbon chain 
with the dissolved PLGA [17]. However, CTAB 
has positive charge and thus it is assumed to 
have an ionic interaction with the negatively 
charged terminal carboxyl groups in the PLGA 
molecules. The polymer used in this study is 
PLGA with low molecular weight and free 
terminal carboxyl group. Consequently, the 
interaction between CTAB and PLGA might be 
stronger than previous studies. This interaction 
restricts PLGA molecule mobility leading to the 
observed higher Tg. Consequently, CTAB had 
anti-plasticising effect. This finding is opposite to 
what reported before that CTAB has plasticising 
effect on PLGA [11]. 
 
CTAB fractionates between the two aqueous and 
oil phases during the fabrication. When we used 
ethyl acetate and vacuum to facilitate the solvent 
diffusion and evaporation, the fast solidification of 
the nanoparticle caused CTAB molecules to 
remain in the oil phase in F2 and vice versa in 
F1. Therefore, CTAB content of the nanoparticles 
is larger in F2 compared to F1 and as a result, 
the Tg of F2 was slightly higher than the Tg of F1 
(43.8 °C compared to 43.3 °C). 
 
At room temperature, CTAB crystal belongs to 
the monoclinic system, being optically anisotropic 
and it undergoes a phase transition at about 102 
°C into an isotropic mesophase on heating [18]. 
The transition can be clearly seen in the second 
heating segment of F1 (Figure 1) but not of F2. 
This indicates the presence of CTAB, or at least 
a portion of it, in its crystalline form in F1. The 
presence of the crystalline phase of CTAB in F1 
helped to conclude that significant amount of 
CTAB was adsorbed on the surface of F1 but 
unlikely in the F2. 
 
The significantly greater increase in the Tg of F3 
and F4 than that of the physical mixture of 
PLGA-CS indicates that chitosan has anti-
plasticising effect. Chitosan molecules anchored 
among PLGA molecules and greatly restricted 
their mobility. This also explains the stability of 
chitosan molecules during washing step, unlike 
CTAB molecules that were prone to desorption. 
Due to the larger molecules of MCS (190 - 310 
kDa compared to 50 - 190 kDa for LCS), MCS 
seems to have stronger effect on the PLGA glass 
transition than LCS. This means that MCS has 
stronger interaction with PLGA compared to 
LCS. The small thermal events appeared after 
150°C in both F3 and F4 may be related to the 
movement of chitosan molecules because 
chitosan can be adsorbed on the PLGA particle 
in different conformations [19]. 
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Contrary to several studies that reported 
positively charged particles whenever CTAB was 
included in the preparation [5,20], this study 
revealed negatively charged particles with CTAB. 
One study reported negatively charged 
nanoparticle from CTAB-modified nanoparticles 
which was further demonstrated to be dependent 
on the type of PLGA and due to CTAB 
desorption from the particles in the washing step 
[11]. This concept was exploited by Singh, 
Ugozzoli [9] whereby the washing steps were 
controlled to obtain different concentrations of 
CTAB in PLGA microparticle. Oster et al [11] 
proposed the formation of reverse micelles 
where the orientation of the hydrophilic, ionised 
head groups of CTAB molecules tend to 
converge inwards the core of the micelle 
masking the positive charges. The desorption of 
CTAB molecules from the particles increased the 
conductivity of CTAB-PLGA nanoparticles. This 
was supported by the dramatic decreased in 
conductivity of the particles subjected to 
extensive washing cycles. 
 
Furthermore, CTAB molecules suffer re-
localisation and re-orientation during 
lyophilisation. It seems that during the 
lyophilisation cycle then re-suspending the 
particles in deionised water, CTAB molecules 
migrated to the surface of the particles orienting 
their polar head to the surface rather than 
arranging themselves in a reversed micelle 
conformation. This led to the zeta potential 
inversion of F1 and F2. In contrast, DSC 
measurements suggest that chitosan strongly 
interacts with the polymeric network of PLGA 
matrix. This reflects the significantly lower 
conductivity reading of F3 and F4 compared to 
F1 and F2 (Table 3). In addition, the strong 
interaction of MCS molecules with PLGA, as 
revealed by DSC, results in presenting less 
amine groups to the particle surface and this 
explains the lower zeta potential of F4 compared 
to F3. 
 
Cationic polymers have often been demonstrated 
to cause membrane toxicity as a result of 
electrostatic interactions with the negatively 
charged glycocalyx of the cellular surface 
[21,22]. Both CTAB and chitosan solutions were 
also reported to be toxic to the cells [11,23]. The 
presence of CTAB molecules on the surface of 
F1 nanoparticles and their readily desorption 
from to the solution give rise to the high toxicity. 
On the other hand, despite the suggested higher 
amount of CTAB molecules in F2, their presence 
in PLGA matrix may reduce the toxicity of this 
formulation. Chitosan-modified nanoparticles (F3 
and F4) exhibited relatively low cytotoxicity which 
can be attributed to the inherited low toxicity of 
chitosan compared to CTAB and the tight 
adhesion of chitosan molecules to the particles. 
 
The very low cell uptake observed in F1 may be 
related to its cytotoxicity as CTAB readily desorb 
from the surface of the particles. The presence of 
some particles in the field could be attributed to 
the exocytosis. Panyam and Labhasetwar [24] 
demonstrated that the amount of nanoparticles 
within the cell was maintained as long as the 
nanoparticles remained in the external medium 
and when the external nanoparticle concentration 
gradient was removed, nanoparticle exocytosis 
started to take place. The presence of free 
nanoparticles in the case of surface-unmodified 
nanoparticles highlights the significance of 
surface modification in the cell uptake. Chitosan 
molecules entangle in PLGA matrix leaving 
portion exposed to the solution facilitating the 
nanoparticle-cell interaction.  
 
The low cell uptake of F1 and the instability of 
the complex with pDNA due to CTAB desorption 
from the particles result in low transfection. Zeta 
potential of F3-pDNA was higher than F4-pDNA 
(Table 3), which may result in better interaction 
with the cells and hence higher transfection 
efficiency. The unexpected high transfection 
observed by F2 may be attributed to the weak 
interaction with pDNA with the aid of CTAB 
molecules in the nanoparticle matrix with their 
positive head towards the surface. These CTAB 
molecules are bound strongly to PLGA in F2, 
unlike in F1. This interaction may be sufficient to 
carry the pDNA into the cell then readily 
dissociate it from the nanoparticles. Similar 
results were obtained by Köping-Höggård, 
Vårum [25] who showed that polyplexes with 
easier dissociation could mediate faster effect 
and thus higher gene expression. 
 
Based on the characterisation results, schematic 
diagrams for the four formulations were drawn as 
shown in Figure 7. F1 is characterised by the 
presence of CTAB in PLGA matrix in the reverse 
micelle configuration converging the ionised 
head groups inwards the core of the micelle. 
CTAB is also adsorbed on the surface with 
partial coverage and crystallises after 
lyophilisation. The overall surface charge is 
negative and CTAB is prone to desorption from 
the particles. On the other hand, F2 is 
characterised by the presence of CTAB mainly in 
the PLGA matrix in the reverse micelle 
configuration. The surface charge was also 
negative but lower than F1 and CTAB is prone to 
desorb slowly from the particles. F3 and F4 are 
characterised by the presence of chitosan in 
PLGA matrix which completely covered the 
nanoparticle surface.  
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Figure 7: Proposed schematic diagrams based on DSC, zeta potential and conductivity results for (1) 
F1 (PLGA nanoparticles modified with CTAB in aqueous phase), (2) F2 (PLGA nanoparticles modified 
with CTAB in oil phase), (3) F3 (PLGA nanoparticles modified with low molecular weight chitosan and 
(4) F4 (PLGA nanoparticles modified with medium molecular weight chitosan). 
 
In addition, chitosan interacts stronger with 
PLGA in F4 than in F3, however, in both 
formulations chitosan is stable in the particles 
and not prone to desorption. This yielded 
positively charged surface, lower cytotoxicity and 





PLGA nanoparticles modified with CTAB or 
chitosan have successfully been prepared. 
Chitosan as a cationic modifier for PLGA 
nanoparticles is superior to CTAB in terms of 
producing particles that have positive zeta 
potential, low cytotoxicity, and high cell uptake 
and transfection. Chitosan-modified 
nanoparticles are more effective for plasmid DNA 
adsorption and protection. This results suggest 
that chitosan-modified PLGA nanoparticles can 
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